Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical Trial

Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical Trial

Anxiety is common among patients with coronary heart disease (CHD) and is associated with a worse prognosis. UNWIND was a 12-week randomized clinical trial comparing exercise and escitalopram to placebo on measures of anxiety, depression, and CHD biomarkers. Primary results of the trial reported tha...

Full description

Bibliographic Details
Main Authors: James A. Blumenthal, Patrick J. Smith, Wei Jiang, Alan Hinderliter, Lana L. Watkins, Benson M. Hoffman, William E. Kraus, Stephanie Mabe, Lawrence Liao, Jonathan Davidson, Andrew Sherwood
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
anxiety
depression
exercise
escitalopram
coronary heart disease
Online Access:https://www.mdpi.com/2308-3425/9/10/320

Internet

https://www.mdpi.com/2308-3425/9/10/320

Similar Items